| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-06 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |